Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,903 JPY | +1.19% | +6.75% | 0.00% |
02:22am | RocketBoots Posts AU$153,000 Cash Inflows in Fiscal Q3 | MT |
Apr. 30 | First trial over Zantac cancer claims set to begin in Chicago | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.05B | |
+9.52% | 322B | |
+13.03% | 75.75B | |
+2.38% | 31.01B | |
+20.26% | 23.74B | |
+9.19% | 14.21B | |
+12.03% | 10.04B | |
+20.37% | 9.14B | |
-7.35% | 6.51B | |
-3.62% | 4.41B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy